Skip to letters
Dear Ms. Bury,
We, the undersigned civil society organisations Générations Futures, Global 2000, PAN Europe and PAN Germany, hereby urge the European Commission to propose the non-renewal of the approval of diflufenican, taking into account the latest scientific and technical knowledge regarding the formation of the toxic and highly persistent metabolite trifluoroacetic acid (TFA). We note with serious concern that EFSA’s peer-review conclusions on diflufenican, published on 11 February 2026, failed to identify TFA formation as a critical concern, an omission inconsistent with the current state of scientific knowledge.